摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Amino-6-methyl-thieno<2,3-b>pyridin-2,4-bis-carbonsaeureamid | 128918-05-8

中文名称
——
中文别名
——
英文名称
3-Amino-6-methyl-thieno<2,3-b>pyridin-2,4-bis-carbonsaeureamid
英文别名
3-Amino-6-methylthieno[2,3-b]pyridine-2,4-dicarboxamide
3-Amino-6-methyl-thieno<2,3-b>pyridin-2,4-bis-carbonsaeureamid化学式
CAS
128918-05-8
化学式
C10H10N4O2S
mdl
——
分子量
250.281
InChiKey
RQCQEZPIWLFJFD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    153
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED 3-AMINO-THIENO[2,3-B] PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AS IKK INHIBITORS<br/>[FR] COMPOSES AMIDE D'ACIDE 3-AMINO-THIENO[2,3-B] PYRIDINE-2-CARBOXYLIQUE SUBSTITUE SERVANT D'INHIBITEURS D'IKK
    申请人:BOEHRINGER INGELHEIM PHARMA
    公开号:WO2005056562A1
    公开(公告)日:2005-06-23
    Disclosed are compounds of formula (I): wherein the variables R1, R2, R3 and Z are described herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    披露了公式(I)的化合物:其中变量R1、R2、R3和Z如本文所述,它们作为IκB激酶(IKK)复合物的激酶活性的抑制剂是有用的。因此,这些化合物在治疗IKK介导的疾病,包括自身免疫性疾病、炎症性疾病和癌症方面是有用的。还披露了包含这些化合物的药物组合物以及制备这些化合物的方法。
  • SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
    申请人:GINN David John
    公开号:US20070293533A1
    公开(公告)日:2007-12-20
    Disclosed are compounds of formula (I): wherein R 1 and R 4 are defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases, cardiovascular disease and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    公开了以下化合物的结构(I):其中R1和R4如本文所定义,这些化合物可用作IκB激酶(IKK)复合物的激酶活性抑制剂。因此,这些化合物在治疗IKK介导的疾病中具有用途,包括自身免疫性疾病、炎症性疾病、心血管疾病和癌症。还公开了包含这些化合物的药物组合物和制备这些化合物的方法。
  • Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    申请人:Cywin L. Charles
    公开号:US20050288285A1
    公开(公告)日:2005-12-29
    Disclosed are compounds of formula (I): wherein R 1 and R 2 are defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    本发明涉及化合物(I)的公开,其中R1和R2在此定义,这些化合物可用作IκB激酶(IKK)复合物的激酶活性抑制剂。因此,这些化合物可用于治疗由IKK介导的疾病,包括自身免疫性疾病、炎症性疾病和癌症。还公开了包含这些化合物的药物组合物和制备这些化合物的过程。
  • Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
    公开号:US20040053957A1
    公开(公告)日:2004-03-18
    Disclosed are compounds of formula (I): 1 wherein R 1 and R 2 are defined herein, which are useful as inhibitors of the kinase activity of the I&kgr;B kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    本发明公开了式(I)的化合物:其中R1和R2在此定义,这些化合物可用作IκB激酶(IKK)复合物的激酶活性抑制剂。因此,这些化合物可用于治疗IKK介导的疾病,包括自身免疫性疾病、炎症性疾病和癌症。本发明还公开了包含这些化合物的制药组合物和制备这些化合物的过程。
  • Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    申请人:Chen Zhidong
    公开号:US20060270671A1
    公开(公告)日:2006-11-30
    Disclosed are methods of treating cancer by administration of compounds according to formula (I): wherein the variables R 1 , R 2 , R 3 and Z are described herein.
    本发明涉及通过给予式(I)所述化合物治疗癌症的方法:其中变量R1、R2、R3和Z的描述如下。
查看更多

同类化合物

钠3-氨基-4,6-二甲基噻吩并[2,3-b]吡啶-2-羧酸酯 脱乙酰基2-O-叔-丁基二甲基硅烷基普拉格雷 羟基(噻吩并[2,3-b]吡啶-3-基)乙腈 盐酸噻氯匹定 甲基4-溴7-氧-6,7-二氢噻吩并[2,3-C]吡啶-2-羧酸酯 甲基3-甲基噻吩并[2,3-c]吡啶-2-羧酸酯 甲基3-氨基噻吩并[2,3-c]吡啶-2-羧酸酯 甲基3-氨基-4-(二甲基氨基)噻吩并[2,3-b]吡啶-2-羧酸酯 甲基3-氨基-4,5,6-三甲基噻吩并[2,3-b]吡啶-2-羧酸酯 甲基2,4-二甲基噻吩并[3,4-b]吡啶-7-羧酸酯 替诺立定 普拉格雷羟基硫内酯 普拉格雷盐酸盐 普拉格雷杂质III 普拉格雷杂质1 普拉格雷杂质 普拉格雷 外消旋-2-(2-氯苯基)-(6,7-二氢-4H-噻吩并[3,2-c]吡啶-5-基)乙腈 噻氯吡啶杂质F 噻氯吡啶杂质E 噻氯匹定杂质8 噻氯匹定N-氧化物 噻氯匹定3-氯异构体 噻氯匹定 噻氯匹丁-d4 噻吩并吡啶酮 噻吩并吡啶-2-甲酸甲酯 噻吩并[3,4-b]吡啶-5,7-二酮 噻吩并[3,2:3,4]环戊二烯并[1,2-b]吖丙因(9CI) 噻吩并[3,2-c]吡啶-3-胺 噻吩并[3,2-c]吡啶-3-羧醛 噻吩并[3,2-c]吡啶-2-羧酸甲酯 噻吩并[3,2-c]吡啶-2-羧酸 噻吩并[3,2-c]吡啶-2-基硼酸 噻吩并[3,2-c]吡啶 噻吩并[3,2-b]吡啶-7-羧酸 噻吩并[3,2-b]吡啶-6-醇 噻吩并[3,2-b]吡啶-6-胺 噻吩并[3,2-b]吡啶-6-羧酸甲酯 噻吩并[3,2-b]吡啶-6-羧酸 噻吩并[3,2-b]吡啶-5-羧酸 噻吩并[3,2-b]吡啶-3-胺 噻吩并[3,2-b]吡啶-2-羧酸甲酯 噻吩并[3,2-b]吡啶-2-羧酸 噻吩并[3,2-b]吡啶-2-甲醇 噻吩并[3,2-C]吡啶-2-硼酸频那醇酯 噻吩并[3,2-B]吡啶-3-羧酸甲酯 噻吩并[2,3-c]吡啶-7-胺 噻吩并[2,3-c]吡啶-7-羧酸甲酯 噻吩并[2,3-c]吡啶-7-羧酸